{"id":210447,"name":"ZELIS HEALTHCARE CORP.","slug":"zelis-healthcare-corp","state":"NJ","country":"United States of America","description":"Health care transparency and engagement platform","totalSpending":580000,"filings":13,"yearlySpending":[{"year":2021,"income":130000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":50000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["AVENUE SOLUTIONS"],"lobbyists":["TRACY SPICER","ELIZABETH BARNETT"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to health care cost transparency","Issues related to health care cost transparency;\n\nTransparency in Coverage final rules (85 FR 72158);\n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260)","Issues related to health care cost transparency;\n\nTransparency in Coverage final rules (85 FR 72158);\n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260);\n\nRequirements Related","Issues related to health care cost transparency; \n\nTransparency in Coverage final rules (85 FR 72158); \n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); \n\nRequirements Rela","Issues related to health care cost transparency; Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Preside"]}